Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

MasterBrand, Inc. Common Stock (NY:MBC)

10.49 -0.04 (-0.38%)
Streaming Delayed Price Updated: 11:17 AM EDT, Jun 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about MasterBrand, Inc. Common Stock

< Previous 1 2 3 Next >
MasterBrand Reports First Quarter 2023 Financial Results
From MasterBrand, Inc.
Via Business Wire
MasterBrand to Announce First Quarter 2023 Results on May 9
From MasterBrand, Inc.
Via Business Wire
6 University Of Michigan Students Make Their Stock Pitches: Bear Case For Household Name Finishes 1st
Six students completed due diligence on a stock of their choice for the Maize and Blue Stock Pitch Competition at the University of Michigan on Friday.  
Via Benzinga
12 Industrials Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Industrials Stocks Moving In Tuesday's After-Market Session
Via Benzinga
MasterBrand Reports Fourth Quarter and Full Year 2022 Financial Results
From MasterBrand, Inc.
Via Business Wire
MasterBrand to Announce Fourth Quarter and Full Year 2022 Results on March 7
From MasterBrand, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For December 19, 2022
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  During Friday's trading, 71 companies set new 52-week lows. 
Via Benzinga
Melco, Ardelyx And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. Cosmos Health Inc. (NASDAQ: COSM) shares dipped 37.7% to $14.33 in... 
Via Benzinga
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session
Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial. 
Via Benzinga
Why Innate Pharma Shares Are Trading Higher By 24%; Here Are 34 Stocks Moving Premarket
Gainers AIM ImmunoTech Inc. (NYSE: AIM) shares rose 82.4% to $0.62 in pre-market trading. AIM ImmunoTech recently reported safety, tolerability and biological activity data for intranasal ampligen in... 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.